Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BDH Industries's share price for the quarter that ended in Mar. 2026 was ₹352.7. BDH Industries's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 5.8 Mil. Therefore, BDH Industries's market cap for the quarter that ended in Mar. 2026 was ₹2,030.5 Mil.
BDH Industries's quarterly market cap
declined
from Sep. 2025 (₹2,616.3 Mil) to Dec. 2025 (₹2,449.3 Mil) and
declined
from Dec. 2025 (₹2,449.3 Mil) to Mar. 2026 (₹2,030.5 Mil).
BDH Industries's annual market cap
declined
from Mar. 2024 (₹1,622.9 Mil) to Mar. 2025 (₹1,513.8 Mil) but then
increased
from Mar. 2025 (₹1,513.8 Mil) to Mar. 2026 (₹2,030.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BDH Industries's Enterprise Value for Today is ₹3,077.2 Mil.
BDH Industries (BOM:524828) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BDH Industries Market Cap Related Terms
BDH Industries Market Cap Historical Data
* Premium members only.
The historical data trend for BDH Industries's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BDH Industries's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BDH Industries Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BDH Industries's Market Cap distribution charts can be found below:
* The bar in red indicates where BDH Industries's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
BDH Industries's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BDH Industries (BOM:524828) has a Market Cap of ₹3,347.0 Mil as of Jul. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BDH Industries and its competitors. According to the industry distribution chart, BDH Industries ranks #747 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 72.9%.
Is BDH Industries' Market Cap too high?
BDH Industries' current Market Cap is ₹3,347.0 Mil. Based on the distribution chart, BDH Industries ranks #747 out of 1024 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, BDH Industries has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BDH Industries' Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BDH Industries ranks #747 out of 1024 companies for Market Cap. This places BDH Industries in the lower half of its industry. The industry median Market Cap is 214.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.03, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BDH Industries and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BDH Industries's current Market Cap is ₹3,347.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BDH Industries stock overvalued right now?
Based on GuruFocus' analysis, BDH Industries (BOM:524828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹391.10, compared to a current price of ₹581.35 — trading 48.6% above its estimated fair value. The current Market Cap is ₹3,347.0 Mil. BDH Industries' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For BDH Industries (BOM:524828), the current Market Cap is ₹3,347.0 Mil as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BDH Industries (BOM:524828) Overvalued in 2026?
Based on GuruFocus' analysis, BDH Industries stock appears to be overvalued.
The current stock price of ₹581.35 is trading 48.6% above its estimated GF Value™ of ₹391.10.
GuruFocus considers BDH Industries to be Significantly Overvalued.
Key valuation signals for BOM:524828:
Market Cap: ₹3,347.0 Mil
GF Value™: ₹391.10 vs. price of ₹581.35 (48.6% above fair value)
No single metric tells the full story. See the BOM:524828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BDH Industries Ltd is an India based pharmaceutical company. It is engaged in the manufacturing of therapeutic formulations including various pharmaceuticals. The company has the following reportable segments; Pharmaceuticals and Renewable Energy. The majority of its revenue is generated from the Pharmaceuticals segment. The company's product portfolio encompasses therapeutic categories including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antiulcerant, antimalarials, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, psychotropic, and others.
78GF Score
Get the complete analysis for BOM:524828
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524828 has been successfully added to your 
